Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
주식 순위 #33388
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
주가
$5.34
시가총액
$7.80M
변동 (1일)
-3.26%
변동 (1년)
4.91%
국가
US
거래 CNS Pharmaceuticals, Inc. (CNSP)

카테고리

CNS Pharmaceuticals, Inc. (CNSP)의 주식 분할 이력
CNS Pharmaceuticals, Inc. 주식 (심볼: CNSP)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 17, 2026에 발생했습니다.
Aug 17, 2026 이전에 매수한 CNSP 주식 1주는 현재 0주의 CNSP 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE